Caitong International Asset Management »

Entrada Therapeutics shares owned by Caitong International Asset Management

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by Caitong International Asset Management from 13F filings

Historical chart of Caitong International Asset Management investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by Caitong International Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by Caitong International Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $339 46 7.37

More positions owned by Caitong International Asset Management

Advanced Micro Devices (AMD)
Intel Corporation (INTC)
Corning Incorporated (GLW)
Strategy Cl A New (MSTR)
Apple (AAPL)
Asml Hldg Nv N Y Registry Shs (ASML)
Bloom Energy Corp Com Cl A (BE)
Oracle Corporation (ORCL)
Seagate Technology Hldngs Pl Ord Shs (STX)
Alphabet Cap Stk Cl A (GOOGL)
Kla Corp Com New (KLAC)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
ON Semiconductor (ON)
Cisco Systems (CSCO)

View all positions for Caitong International Asset Management

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
BlackRock
Merck & Co
Vanguard Capital Management
MPM Oncology Impact Management
TCG Crossover Management
Wellington Management Company
Millennium Management
StepStone
Geode Capital Management
AQR Capital Management
State Street Corporation
T. Rowe Price Associates
Jpmorgan Chase & Co

View all funds holding Entrada Therapeutics